15LBA High tumoral IFNγ mRNA, PD-L1 protein, and combined IFNγ mRNA/PD-L1 protein expression associates with response to durvalumab (anti-PD-L1) monotherapy in NSCLC patientsBrandon W. Higgs, K. Ranade, John A. Blake-Haskins et al.|European Journal of Cancer|2015Cited by 30